AxoGen, Inc. (AXGN)
USD 17.04
(-3.67%)
USD 17.04
(-3.67%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -21.46 Million USD | 27.75% |
| 2022 | -29.7 Million USD | -16.88% |
| 2021 | -25.41 Million USD | -9.64% |
| 2020 | -23.18 Million USD | 26.19% |
| 2019 | -31.4 Million USD | -53.2% |
| 2018 | -20.5 Million USD | -157.82% |
| 2017 | -7.95 Million USD | 2.2% |
| 2016 | -8.12 Million USD | 12.27% |
| 2015 | -9.26 Million USD | 5.45% |
| 2014 | -9.8 Million USD | -2.17% |
| 2013 | -9.59 Million USD | -22.95% |
| 2012 | -7.8 Million USD | -11.96% |
| 2011 | -6.96 Million USD | -276.99% |
| 2010 | -1.84 Million USD | -111.59% |
| 2009 | 15.95 Million USD | 1609.83% |
| 2008 | -1.05 Million USD | -32.11% |
| 2007 | -799.92 Thousand USD | -101.3% |
| 2006 | -397.37 Thousand USD | -21.7% |
| 2005 | -326.52 Thousand USD | -162.05% |
| 2004 | -124.6 Thousand USD | 89.99% |
| 2003 | -1.24 Million USD | 50.03% |
| 2002 | -2.49 Million USD | 24.84% |
| 2001 | -3.31 Million USD | -14.71% |
| 2000 | -2.89 Million USD | -60.58% |
| 1999 | -1.8 Million USD | -350.0% |
| 1998 | -400 Thousand USD | -500.0% |
| 1997 | 100 Thousand USD | 116.67% |
| 1996 | -600 Thousand USD | -500.0% |
| 1995 | -100 Thousand USD | -112.5% |
| 1994 | 800 Thousand USD | 14.29% |
| 1993 | 700 Thousand USD | -41.67% |
| 1992 | 1.2 Million USD | 9.09% |
| 1991 | 1.1 Million USD | 83.33% |
| 1990 | 600 Thousand USD | -14.29% |
| 1989 | 700 Thousand USD | -30.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -428 Thousand USD | 90.61% |
| 2024 Q1 | -4.56 Million USD | -42.77% |
| 2023 Q1 | -7.34 Million USD | -30.9% |
| 2023 Q2 | -6.9 Million USD | 5.98% |
| 2023 Q3 | -4.02 Million USD | 41.68% |
| 2023 FY | -21.46 Million USD | 27.75% |
| 2023 Q4 | -3.19 Million USD | 20.65% |
| 2022 Q3 | -4.85 Million USD | 38.73% |
| 2022 Q4 | -5.6 Million USD | -15.51% |
| 2022 FY | -29.7 Million USD | -16.88% |
| 2022 Q1 | -11.32 Million USD | -111.47% |
| 2022 Q2 | -7.92 Million USD | 30.0% |
| 2021 Q4 | -5.35 Million USD | 19.97% |
| 2021 Q2 | -7.15 Million USD | -15.02% |
| 2021 Q1 | -6.22 Million USD | -15.74% |
| 2021 Q3 | -6.68 Million USD | 6.5% |
| 2021 FY | -25.41 Million USD | -9.64% |
| 2020 Q1 | -8.5 Million USD | -14.69% |
| 2020 FY | -23.18 Million USD | 26.19% |
| 2020 Q2 | -8.25 Million USD | 3.0% |
| 2020 Q3 | -1.04 Million USD | 87.34% |
| 2020 Q4 | -5.37 Million USD | -414.26% |
| 2019 Q3 | -6.11 Million USD | 20.33% |
| 2019 Q1 | -10.2 Million USD | -74.44% |
| 2019 Q2 | -7.67 Million USD | 24.81% |
| 2019 FY | -31.4 Million USD | -53.2% |
| 2019 Q4 | -7.41 Million USD | -21.38% |
| 2018 Q2 | -4.81 Million USD | 3.49% |
| 2018 Q1 | -4.99 Million USD | -176.26% |
| 2018 Q3 | -4.83 Million USD | -0.35% |
| 2018 FY | -20.5 Million USD | -157.82% |
| 2018 Q4 | -5.84 Million USD | -20.98% |
| 2017 Q4 | -1.8 Million USD | -20.59% |
| 2017 FY | -7.95 Million USD | 2.2% |
| 2017 Q2 | -1.44 Million USD | 54.83% |
| 2017 Q3 | -1.49 Million USD | -3.65% |
| 2017 Q1 | -3.2 Million USD | -17.68% |
| 2016 FY | -8.12 Million USD | 12.27% |
| 2016 Q4 | -2.71 Million USD | -130.13% |
| 2016 Q2 | -1.6 Million USD | 38.77% |
| 2016 Q3 | -1.18 Million USD | 26.42% |
| 2016 Q1 | -2.62 Million USD | 1.1% |
| 2015 Q3 | -1.91 Million USD | 10.93% |
| 2015 Q1 | -2.54 Million USD | 6.1% |
| 2015 FY | -9.26 Million USD | 5.45% |
| 2015 Q4 | -2.65 Million USD | -38.28% |
| 2015 Q2 | -2.15 Million USD | 15.35% |
| 2014 Q2 | -2.29 Million USD | 23.18% |
| 2014 FY | -9.8 Million USD | -2.17% |
| 2014 Q1 | -2.99 Million USD | -6.93% |
| 2014 Q3 | -1.8 Million USD | 21.54% |
| 2014 Q4 | -2.7 Million USD | -50.26% |
| 2013 FY | -9.59 Million USD | -22.95% |
| 2013 Q4 | -2.79 Million USD | -22.85% |
| 2013 Q3 | -2.27 Million USD | -3.77% |
| 2013 Q2 | -2.19 Million USD | 5.56% |
| 2013 Q1 | -2.32 Million USD | -4.15% |
| 2012 Q4 | -2.23 Million USD | -9.21% |
| 2012 Q3 | -2.04 Million USD | -28.75% |
| 2012 Q2 | -1.58 Million USD | 18.25% |
| 2012 Q1 | -1.94 Million USD | 2.42% |
| 2012 FY | -7.8 Million USD | -11.96% |
| 2011 Q4 | -1.98 Million USD | 24.27% |
| 2011 FY | -6.96 Million USD | -276.99% |
| 2011 Q1 | 1.48 Million USD | 385.17% |
| 2011 Q2 | 513.18 Thousand USD | -65.49% |
| 2011 Q3 | -2.62 Million USD | -611.79% |
| 2010 FY | -1.84 Million USD | -111.59% |
| 2010 Q4 | -521.45 Thousand USD | 15.0% |
| 2010 Q1 | -374.94 Thousand USD | -102.33% |
| 2010 Q2 | -338.62 Thousand USD | 9.69% |
| 2010 Q3 | -613.5 Thousand USD | -81.18% |
| 2009 FY | 15.95 Million USD | 1609.83% |
| 2009 Q1 | -134.99 Thousand USD | -10.0% |
| 2009 Q2 | 138.82 Thousand USD | 202.84% |
| 2009 Q3 | -131 Thousand USD | -194.37% |
| 2009 Q4 | 16.08 Million USD | 12376.5% |
| 2008 Q4 | -122.71 Thousand USD | 79.05% |
| 2008 Q2 | -181.34 Thousand USD | -8.66% |
| 2008 Q1 | -166.88 Thousand USD | -458.55% |
| 2008 FY | -1.05 Million USD | -32.11% |
| 2008 Q3 | -585.84 Thousand USD | -223.06% |
| 2007 Q4 | -29.87 Thousand USD | 93.63% |
| 2007 Q3 | -469.28 Thousand USD | -173.54% |
| 2007 Q2 | -171.55 Thousand USD | -32.78% |
| 2007 Q1 | -129.2 Thousand USD | 27.34% |
| 2007 FY | -799.92 Thousand USD | -101.3% |
| 2006 FY | -397.37 Thousand USD | -21.7% |
| 2006 Q4 | -177.81 Thousand USD | -187.15% |
| 2006 Q3 | -61.92 Thousand USD | 41.61% |
| 2006 Q2 | -106.06 Thousand USD | -105.65% |
| 2006 Q1 | -51.57 Thousand USD | -137.49% |
| 2005 Q3 | -19.13 Thousand USD | 71.29% |
| 2005 FY | -326.52 Thousand USD | -162.05% |
| 2005 Q4 | 137.57 Thousand USD | 819.05% |
| 2005 Q2 | -66.65 Thousand USD | 82.38% |
| 2005 Q1 | -378.31 Thousand USD | -309.35% |
| 2004 Q1 | 79.67 Thousand USD | 141.84% |
| 2004 Q3 | -141.13 Thousand USD | -9477.87% |
| 2004 Q4 | 180.7 Thousand USD | 228.04% |
| 2004 Q2 | 1505.00 USD | -98.11% |
| 2004 FY | -124.6 Thousand USD | 89.99% |
| 2003 Q3 | -336.77 Thousand USD | 21.18% |
| 2003 Q4 | -190.44 Thousand USD | 43.45% |
| 2003 Q1 | -290.67 Thousand USD | 55.8% |
| 2003 FY | -1.24 Million USD | 50.03% |
| 2003 Q2 | -427.27 Thousand USD | -46.99% |
| 2002 Q2 | -730 Thousand USD | 4.98% |
| 2002 FY | -2.49 Million USD | 24.84% |
| 2002 Q3 | -335.92 Thousand USD | 53.98% |
| 2002 Q4 | -657.69 Thousand USD | -95.79% |
| 2002 Q1 | -768.26 Thousand USD | 0.0% |
| 2001 Q3 | -1.19 Million USD | 20.98% |
| 2001 FY | -3.31 Million USD | -14.71% |
| 2001 Q1 | -601.44 Thousand USD | 6.07% |
| 2001 Q2 | -1.51 Million USD | -151.22% |
| 2000 FY | -2.89 Million USD | -60.58% |
| 2000 Q2 | -829 Thousand USD | -30.09% |
| 2000 Q1 | -637.25 Thousand USD | 20.34% |
| 2000 Q4 | -640.32 Thousand USD | -13.76% |
| 2000 Q3 | -562.87 Thousand USD | 32.1% |
| 1999 Q1 | -300 Thousand USD | 57.14% |
| 1999 Q2 | -500 Thousand USD | -66.67% |
| 1999 Q3 | -700 Thousand USD | -40.0% |
| 1999 Q4 | -800 Thousand USD | -14.29% |
| 1999 FY | -1.8 Million USD | -350.0% |
| 1998 FY | -400 Thousand USD | -500.0% |
| 1998 Q3 | -200 Thousand USD | 0.0% |
| 1998 Q4 | -700 Thousand USD | -250.0% |
| 1998 Q2 | -200 Thousand USD | 33.33% |
| 1998 Q1 | -300 Thousand USD | -200.0% |
| 1997 Q1 | 1.6 Million USD | 900.0% |
| 1997 FY | 100 Thousand USD | 116.67% |
| 1997 Q4 | -100 Thousand USD | -150.0% |
| 1997 Q3 | 200 Thousand USD | 0.0% |
| 1997 Q2 | 200 Thousand USD | -87.5% |
| 1996 FY | -600 Thousand USD | -500.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q4 | -200 Thousand USD | 0.0% |
| 1996 Q2 | - USD | -100.0% |
| 1996 Q1 | 200 Thousand USD | 128.57% |
| 1995 Q3 | - USD | 100.0% |
| 1995 Q1 | 300 Thousand USD | 0.0% |
| 1995 FY | -100 Thousand USD | -112.5% |
| 1995 Q4 | -700 Thousand USD | 0.0% |
| 1995 Q2 | -400 Thousand USD | -233.33% |
| 1994 Q1 | 100 Thousand USD | -50.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 FY | 800 Thousand USD | 14.29% |
| 1994 Q4 | - USD | 0.0% |
| 1994 Q2 | - USD | -100.0% |
| 1993 FY | 700 Thousand USD | -41.67% |
| 1993 Q3 | 500 Thousand USD | 150.0% |
| 1993 Q4 | 200 Thousand USD | -60.0% |
| 1993 Q1 | 200 Thousand USD | 0.0% |
| 1993 Q2 | 200 Thousand USD | 0.0% |
| 1992 Q2 | 300 Thousand USD | 0.0% |
| 1992 Q4 | - USD | -100.0% |
| 1992 Q3 | 300 Thousand USD | 0.0% |
| 1992 Q1 | 300 Thousand USD | 0.0% |
| 1992 FY | 1.2 Million USD | 9.09% |
| 1991 Q1 | 200 Thousand USD | 0.0% |
| 1991 Q4 | 300 Thousand USD | 0.0% |
| 1991 FY | 1.1 Million USD | 83.33% |
| 1991 Q3 | 300 Thousand USD | 0.0% |
| 1991 Q2 | 300 Thousand USD | 50.0% |
| 1990 FY | 600 Thousand USD | -14.29% |
| 1990 Q2 | -2.2 Million USD | -257.14% |
| 1990 Q1 | 1.4 Million USD | 16.67% |
| 1990 Q4 | 200 Thousand USD | -33.33% |
| 1990 Q3 | 300 Thousand USD | 113.64% |
| 1989 Q1 | 1.6 Million USD | -5.88% |
| 1989 FY | 700 Thousand USD | -30.0% |
| 1989 Q4 | 1.2 Million USD | 500.0% |
| 1989 Q3 | 200 Thousand USD | 104.88% |
| 1989 Q2 | -4.1 Million USD | -356.25% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -49.446% |
| Cerus Corporation | -30.05 Million USD | 28.586% |
| OrthoPediatrics Corp. | -25.76 Million USD | 16.704% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -102.065% |
| Talis Biomedical Corporation | -66.81 Million USD | 67.878% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -24.086% |
| Inogen, Inc. | -109.38 Million USD | 80.38% |
| Spectral AI, Inc. | -12.98 Million USD | -65.296% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 65.71% |
| CVRx, Inc. | -43.1 Million USD | 50.208% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -508.333% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -72.691% |
| Orthofix Medical Inc. | -139.11 Million USD | 84.572% |
| Venus Concept Inc. | -28.3 Million USD | 24.187% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 60.276% |
| Bioventus Inc. | -81.72 Million USD | 73.739% |
| BrainsWay Ltd. | -4.92 Million USD | -335.6% |
| Envoy Medical, Inc. | -18.37 Million USD | -16.825% |
| electroCore, Inc. | -18.8 Million USD | -14.129% |
| IceCure Medical Ltd | -15.57 Million USD | -37.789% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 55.732% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -24.287% |
| MaxCyte, Inc. | -48.29 Million USD | 55.564% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -79.519% |
| Nexalin Technology, Inc. | -5.69 Million USD | -276.771% |
| PAVmed Inc | -68.79 Million USD | 68.803% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 62.056% |
| RxSight, Inc. | -50.08 Million USD | 57.149% |
| Sight Sciences, Inc. | -57.27 Million USD | 62.527% |
| SI-BONE, Inc. | -46.93 Million USD | 54.269% |
| TELA Bio, Inc. | -44.07 Million USD | 51.306% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 60.366% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 58.268% |
| LivaNova PLC | -68.49 Million USD | 68.668% |
| 908 Devices Inc. | -42.75 Million USD | 49.806% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 87.622% |
| Nemaura Medical Inc. | -9.59 Million USD | -123.674% |
| NeuroPace, Inc. | -27.17 Million USD | 21.02% |
| LENSAR, Inc. | -12.22 Million USD | -75.501% |
| Apyx Medical Corporation | -17.25 Million USD | -24.353% |
| Cutera, Inc. | -156.23 Million USD | 86.263% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -149.442% |
| BioSig Technologies, Inc. | -28.51 Million USD | 24.726% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 75.511% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 4.384% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 119.244% |
| Axonics, Inc. | -26.05 Million USD | 17.634% |
| Outset Medical, Inc. | -169.77 Million USD | 87.358% |
| IRIDEX Corporation | -10 Million USD | -114.47% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 80.341% |
| IRadimed Corporation | 20.03 Million USD | 207.12% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -160.303% |
| INVO Bioscience, Inc. | -6.76 Million USD | -217.15% |
| Telesis Bio, Inc. | -35.15 Million USD | 38.942% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 249.77% |
| Varex Imaging Corporation | 32.1 Million USD | 166.86% |
| Quipt Home Medical Corp. | 3.91 Million USD | 647.64% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -76.889% |
| Pulmonx Corporation | -61.93 Million USD | 65.348% |
| Dynatronics Corporation | -2.27 Million USD | -844.195% |
| Modular Medical, Inc. | -17.52 Million USD | -22.437% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -46.608% |
| Semler Scientific, Inc. | 22.25 Million USD | 196.432% |
| InMode Ltd. | 195.66 Million USD | 110.969% |
| Bruker Corporation | 436.9 Million USD | 104.912% |
| Cytosorbents Corporation | -31.2 Million USD | 31.232% |
| DexCom, Inc. | 597.7 Million USD | 103.591% |
| Align Technology, Inc. | 643.33 Million USD | 103.336% |
| Viveve Medical, Inc. | -21.55 Million USD | 0.422% |
| ZimVie Inc. | -30.93 Million USD | 30.631% |
| Movano Inc. | -29.69 Million USD | 27.713% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 22.923% |
| Nexalin Technology, Inc. | -5.69 Million USD | -276.771% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -508.333% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 90.798% |
| Profound Medical Corp. | -28.61 Million USD | 25.0% |
| Insulet Corporation | 220 Million USD | 109.755% |
| enVVeno Medical Corporation | -25.23 Million USD | 14.962% |
| Surmodics, Inc. | -5.64 Million USD | -280.195% |
| iCAD, Inc. | -7.68 Million USD | -179.126% |
| Nuwellis, Inc. | -17.63 Million USD | -21.736% |
| Biotricity, Inc. | -8.82 Million USD | -143.105% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 82.852% |
| Aethlon Medical, Inc. | -12.63 Million USD | -69.84% |
| InspireMD, Inc. | -21.14 Million USD | -1.509% |
| PAVmed Inc. | -68.79 Million USD | 68.803% |
| BIOLASE, Inc. | -17.93 Million USD | -19.652% |
| Beyond Air, Inc. | -63 Million USD | 65.937% |
| FONAR Corporation | 16.53 Million USD | 229.795% |
| Vivani Medical, Inc. | -26.96 Million USD | 20.408% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 218.962% |
| Inari Medical, Inc. | -14.03 Million USD | -52.95% |
| UFP Technologies, Inc. | 57.66 Million USD | 137.219% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -335.547% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -240.355% |
| Tenon Medical, Inc. | -15.72 Million USD | -36.466% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -187.155% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 49.745% |
| AdaptHealth Corp. | -598.4 Million USD | 96.413% |
| Sintx Technologies, Inc. | -13.35 Million USD | -60.668% |
| NanoVibronix, Inc. | -3.43 Million USD | -524.622% |
| Quanterix Corporation | -49.7 Million USD | 56.818% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -76.889% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -5518.325% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 93.583% |
| TransMedics Group, Inc. | -28.72 Million USD | 25.29% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 9.106% |
| NeuroMetrix, Inc. | -7.15 Million USD | -200.104% |
| Hyperfine, Inc. | -48.11 Million USD | 55.394% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 66.995% |
| Biomerica, Inc. | -6.36 Million USD | -237.082% |
| Bone Biologics Corporation | -9.42 Million USD | -127.634% |
| AVITA Medical, Inc. | -40.4 Million USD | 46.879% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -108.142% |
| Silk Road Medical, Inc | -59.27 Million USD | 63.79% |